Onsior® (robenacoxib) is available in two formulations, so it’s
convenient to administer in the hospital and at home.
1 mg/kg (0.45 mg/lb) orally once daily for up to maximum of 3 days. Use the lowest effective dose for the shortest duration consistent with individual response.
Administer first dose approximately 30 minutes before surgery.
2 mg/kg (0.91 mg/lb) subcutaneously once daily for up to a maximum of 3 days.
Administer first dose approximately 30 minutes prior to surgery.
Subsequent doses can be given via subcutaneous injection or interchanged with oral tablets in cats ≥ 5.5 lbs and ≥ 4 months of age.
Onsior can be given for up to a maximum of three total doses over three days not to exceed one dose per day.
Administer the first Onsior dose approximately 45 minutes before soft-tissue surgery.
Administer (or instruct the owner to administer) the second Onsior dose approximately 24 hours after the first dose.
Administer (or instruct the owner to administer) the third Onsior dose approximately 24 hours after the second dose.
ONSIOR tablets for Cats are indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration, in cats ≥ 5.5 lbs and ≥ 4 months of age; for up to a maximum of 3 days.
ONSIOR injection is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration in cats ≥ 4 months of age; for up to a maximum of 3 days.
Do not use in cats that have hypersensitivity to robenacoxib or known intolerance to NSAIDs. Do not administer Onsior tablets or injection in conjunction with any other NSAID or corticosteroid. Do not use for more than 3 days. A thorough history and physical exam including appropriate testing should be conducted before initiation of a NSAID therapy. Owners should be advised to observe for signs of potential drug toxicity. Stop administration of ONSIOR if appetite decreases or if the cat becomes lethargic. The use of ONSIOR has not been evaluated in cats used for breeding, or in pregnant or lactating cats or in cats with cardiac disease. As a class, cyclo-oxygenase inhibitory NSAIDS may be associated with gastrointestinal, renal, and hepatic toxicity. For full prescribing information see label links below.
ONSIOR injection: For subcutaneous use in cats ≥ 4 months of age. Safety has not been demonstrated for intravenous or intramuscular administration. The most common adverse reactions were incision site infection, increased incision site bleeding, vomiting, inappetence and lethargy.
ONSIOR tablets for Cats: For oral use in cats ≥ 5.5 lbs and ≥ 4 months of age only. The most common adverse events are anorexia, depression, vomiting, elevated BUN, elevated creatinine, and renal insufficiency/failure.
©2021 Elanco or its affiliates. Onsior, Elanco, and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-19-1369(3)